Antigen self-anchoring onto bacteriophage T5 capsid-like particles for vaccine design
E. VERNHES, L. LARBI CHERIF, N. DUCROT, M. OULDALI, L. ZIG, N. d. SIDIBE, S. HOOS, L. RAMIREZ-CHAMORRO, M. RENOUARD, O. ROSSIER, P. ENGLAND, G. SCHOEHN, P. BOULANGER, K. BENIHOUD
Abstract
The promises of vaccines based on virus-like particles stimulate demand for universal non-infectious virus-like platforms that can be efficiently grafted with large antigens. Here we harnessed the modularity and extreme affinity of the decoration protein pb10 for the capsid of bacteriophage T5. SPR experiments demonstrated that pb10 fused to mCherry or to the model antigen ovalbumin (Ova) retained picomolar affinity for DNA-free T5 capsid-like particles (T5-CLPs), while cryo-EM studies attested to the full occupancy of the 120 capsid binding sites. Mice immunisation with CLP-bound pb10-Ova chimeras elicited strong long-lasting anti-Ova humoral responses involving a large panel of isotypes, as well as CD8+ T cell responses, without any extrinsic adjuvant. Therefore, T5-CLP constitutes the first DNA-free bacteriophage capsid able to irreversibly display a regular array of large antigens through highly efficient chemical-free anchoring. Its ability to elicit robust immune responses paves the way for further development of this novel vaccination platform.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Decoration of Burkholderia Hcp1 protein to virus-like particles as a vaccine delivery platform.
N. Khakhum, N. Baruch-Torres, … A. G. Torres·bioRxiv·Jan 17, 2024
- VelcroVax: a bolt-on vaccine platform technology improves antibody titres against a viral glycoprotein in mice
N. J. Stonehouse, N. J. Kingston, … D. J. Rowlands·bioRxiv·Apr 22, 2022
- Bacteriophage T4 Vaccine Platform for Next-generation Influenza Vaccine Development
- PreS1-decorated recombinant adenovirus encoding HBV antigens generates neutralizing humoral and cellular immunity
Rebecca A Russell, James B. Lok, … Matthew D. J. Dicks·bioRxiv·Jan 30, 2026
- A modular platform for on-demand vaccine self-assembly enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens
Kevin B. Weyant, Julie Liao, … Matthew P. DeLisa·bioRxiv·Aug 24, 2021
- A chimeric Ad5-Envp-VLP vaccine platform confers broad-spectrum immunity against emerging and re-emerging pathogens
Yuan Zhang, Caiqian Wang, … Ling Zhao·bioRxiv·Jul 3, 2025